ElevateBio key facts
as of Oct 2026- It has raised $926.0M across 2 recorded rounds; the latest was Later Stage VC (Series D) ($401.0M) in May 2023.
- 4 institutional filers report fund marks on ElevateBio across 36 filings.
- ·Watch ElevateBio: the Monday email on marks, rounds and moves
Institutional fund marks on ElevateBio
4 filers · latest Jul 20264 SEC-registered funds reported 36 fair-value marks on ElevateBio between Apr 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View
ElevateBio funding rounds
2 roundsRecent activity
In the last 90 days, ElevateBio's record added 1 institutional fund mark (latest period Jul 2026).
How much has ElevateBio raised?
ElevateBio has raised $926 million across 2 recorded rounds since 2021. The largest was a $525 million Series C in Jan 2021; the most recent was a $401 million Series D in May 2023.
Institutional holders and vehicles
4 SEC-registered funds reported 36 fair-value marks on ElevateBio between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
About ElevateBio
- Industry
- Discovery Tools (Healthcare)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.